GHIF Makes $6 Million Loan to Atomo Diagnostics

Press Release ### Atomo Secures $6 Million from the Global Health Investment Fund The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance January 13, 2016 (SYDNEY and NEW YORK): The Global Health [...]

By |2018-02-23T14:44:40+00:00January 14th, 2016|Uncategorized|0 Comments
Read More

GHIF-Backed EuBiologics Earns WHO Endorsement for Euvichol

From the World Health Organization:   Cholera vaccine supply set to double, easing global shortage 8 January 2016 Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global [...]

By |2018-02-23T14:44:40+00:00January 10th, 2016|Uncategorized|0 Comments
Read More

Important Information

This website does not constitute an offer or solicitation with respect to interests in GHIF or any other securities. Offers and sales of interests in GHIF have not been and will not be registered under the U.S. Securities Act and such interests may be sold only to accredited investors. Neither the U.S. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of an investment in GHIF or the accuracy or adequacy of this website. Interests in GHIF are not subject to the protections of the U.S. Investment Company Act of 1940.
Copyright 2016 Global Health Investment Advisors, LLC | All Rights Reserved | Powered by WordPress | Theme Fusion
Go to Top